Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB01168_nanopub.RA-Pl0NCPas5ghg7-wvYxHWtudoIw9QY0QB7A2E6TaV4I#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB01168 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB01168 label "DDI between Zolmitriptan and Procarbazine - The MAO inhibitor, procarbazine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing procarbazine are contraindicated. [drugbank_resource:DB00315_DB01168]" assertion.
- drugbank_resource:DB00315_DB01168 identifier "drugbank_resource:DB00315_DB01168" assertion.
- drugbank_resource:DB00315_DB01168 title "DDI between Zolmitriptan and Procarbazine - The MAO inhibitor, procarbazine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing procarbazine are contraindicated." assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB01168 assertion.
- drugbank:DB01168 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB01168 assertion.